Extraordinary Index Rebalancing in the Solactive China Healthcare Disruption Index | June 2021

Due to the IPO of ANGELALIGN TECHNOLOGY INC, the company will be added via an extraordinary rebalance effective open 28.06.2021.

In the extraordinary rebalance the following composition will be implemented effective open 28.06.2021:

3SBIO INC
AK MEDICAL HOLDINGS LTD
AKESO INC
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD
ALPHAMAB ONCOLOGY
ANGELALIGN TECHNOLOGY INC
BEIGENE LTD
CANSINO BIOLOGICS INC
CHINA MEDICAL SYSTEM HOLDINGS LTD
EVEREST MEDICINES LTD
GENSCRIPT BIOTECH CORP
HANSOH PHARMACEUTICAL GROUP CO
INNOCARE PHARMA LTD
INNOVENT BIOLOGICS INC
JD HEALTH INTERNATIONAL INC
JOINN LABORATORIES CHINA C-H
KANGJI MEDICAL HOLDINGS LTD
KINTOR PHARMACEUTICAL LTD
LIFETECH SCIENTIFIC CORP
MICROPORT CARDIOFLOW MEDTECH
MICROPORT SCIENTIFIC CORP
NEW HORIZON HEALTH LTD
PEIJIA MEDICAL LTD
PING AN HEALTHCARE AND TECHNOL
REMEGEN CO LTD-H
SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD
SHANGHAI JUNSHI BIOSCIENCES CO LTD
SIMCERE PHARMACEUTICAL GROUP
SINO BIOPHARMACEUTICAL LTD ORD
VENUS MEDTECH HANGZHOU INC
VIVA BIOTECH HOLDINGS
WUXI APPTEC CO LTD
WUXI BIOLOGICS CAYMAN INC
YIDU TECH INC
ZAI LAB LTD